UNI-EN 38:Current report 38 re insiders transactions
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 38 | / | 2014 | | ||||||
Date of issue: | 2014-04-07 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
Current report 38 re insiders transactions | |||||||||||
Official market - legal basis | |||||||||||
Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
Sopharma AD (the “Company") announces that it was notified by Mr. Ognian Donev, Chairman of the Board of Directors that the company “Donev Investments Holding AD" related to him, executed the following transactions related to shares in the Company: Date and time Operation Number Unit price of the of (BGN) settlement shares 02.04.2014 Buy 500 4.540 02.04.2014 Buy 2000 4.510 02.04.2014 Buy 500 4.515 02.04.2014 Buy 1000 4.511 02.04.2014 Buy 4000 4.510 02.04.2014 Buy 1500 4.510 03.04.2014 Buy 2000 4.505 03.04.2014 Buy 3000 4.500 03.04.2014 Buy 300 4.520 03.04.2014 Buy 1000 4.500 03.04.2014 Buy 750 4.500 03.04.2014 Buy 1000 4.500 03.04.2014 Buy 1000 4.500 03.04.2014 Buy 1000 4.500 03.04.2014 Buy 720 4.500 03.04.2014 Buy 280 4.500 03.04.2014 Buy 40 4.500 03.04.2014 Buy 399 4.500 03.04.2014 Buy 500 4.510 03.04.2014 Buy 500 4.510 04.04.2014 Buy 1000 4.500 01.04.2014 Sale 4000 4.6 03.04.2014 Sale 500 4.599 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
Current report 38 re insiders transactions.doc Current report 38 re insiders transactions.doc | Current report 38 re insiders transactions |
SOPHARMA AD | |||||||||||||
(fullname of the issuer) | |||||||||||||
SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
1220 | Sofia | ||||||||||||
(post code) | (city) | ||||||||||||
IlienskoShosse | 16 | ||||||||||||
(street) | (number) | ||||||||||||
+359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nd | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2014-04-07 | Ognian Donev | Executive director |
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 9.0 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.